---
title: "Follistatin 344 vs IGF-1 LR3: vial sizes, prices, specs"
description: "Follistatin 344 vs IGF-1 LR3: Follistatin 344 from £34.99 (2 sizes), IGF-1 LR3 from £9.80 (2 sizes)."
canonical: https://www.sablepeptides.co.uk/versus/follistatin-344/igf-1-lr3
dateModified: 2026-11-09
publisher: Sable Peptides Limited (UK company 17488610)
note: Research use only. Not for human or veterinary use.
---

Comparison · not a ranking

# Follistatin 344 compared with IGF-1 LR3

Follistatin 344 and IGF-1 LR3 are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.

Last verified 9 Nov 2026. UK prices checked daily.

Follistatin 344 and IGF-1 LR3 are separate compounds. Follistatin 344 is a recombinant glycoprotein, while IGF-1 LR3 is a recombinant protein analogue (83 residues). Follistatin 344 has no sourced formula or molecular weight on its reference record yet. IGF-1 LR3: 9111.0 g/mol, CAS 143045-27-6. Each has its own reference record, which lists the source for every figure above. Sable Peptides, a UK supplier operating since 2019, lists both as lyophilised research material; every vial carries a lot number and a certificate of analysis exists for every lot — request yours at /coa-request and we email it within 2 hours. This intro compares identity only and ranks neither compound. Research use only. Not a medicine. Not for human or veterinary use.

Sources: [gsrs.ncats.nih.gov](https://gsrs.ncats.nih.gov/ginas/app/beta/substances/M9L22Y19H9) · [www.sablepeptides.co.uk](https://www.sablepeptides.co.uk/ref/igf-1-lr3)

[/ref/follistatin-344](https://www.sablepeptides.co.uk/ref/follistatin-344) · [/ref/igf-1-lr3](https://www.sablepeptides.co.uk/ref/igf-1-lr3)

Follistatin 344 and IGF-1 LR3 are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/follistatin-344/igf-1-lr3. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.

Research use only. Not a medicine. Not for human or veterinary use. [Disclaimer](/disclaimer)

| Amount | Follistatin 344 | IGF-1 LR3 |
| --- | --- | --- |
| 1 mg | £38.95 | £33.95 |

## Reference facts

| Fact | Follistatin 344 | IGF-1 LR3 |
| --- | --- | --- |
| Molecular weight | – | 9111.0 g/mol |
| Compound class | recombinant glycoprotein | recombinant protein analogue (83 residues) |

Sources: [www.sigmaaldrich.com](https://www.sigmaaldrich.com/GB/en/technical-documents/technical-article/protein-biology/protein-structural-analysis/peptide-stability), [www.sigmaaldrich.com](https://www.sigmaaldrich.com/GB/en/product/sigma/i1271) Verified 2026-11-09

Category

Follistatin 344Analogues

IGF-1 LR3Analogues

Research use only

Follistatin 344Yes

IGF-1 LR3Yes

Vials

Follistatin 3442

IGF-1 LR32

Record

Follistatin 344follistatin-344

IGF-1 LR3igf-1-lr3

[Follistatin 344](/follistatin-344-uk) · [IGF-1 LR3](/igf-1-lr3-uk)

## Questions this page answers

How does Follistatin 344 compare with IGF-1 LR3?

Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.

Which is better?

This page does not say. It does not rank safety, strength, or effect.

What is the lowest catalogue price per mg for Follistatin 344 and IGF-1 LR3?

Follistatin 344: £38.95/mg on the 1 mg vial (£38.95). IGF-1 LR3: £33.95/mg on the 1 mg vial (£33.95). Different compounds; this is a catalogue price fact, not a ranking.

How many vial sizes are listed for each?

Follistatin 344: 0.2 mg, 1 mg. IGF-1 LR3: 0.1 mg, 1 mg.

## Both compounds

-   [follistatin 344 research vial](/product/follistatin-344-1mg)
-   [follistatin 344 reference data](/ref/follistatin-344)
-   [follistatin 344 research overview](/learn/follistatin-344)
-   [igf 1 lr3 research vial](/product/igf-1-lr3-1mg)
-   [igf 1 lr3 reference data](/ref/igf-1-lr3)
-   [igf 1 lr3 research overview](/learn/igf-1-lr3)

## Related research

-   [IGF-1 LR3 research brief](/learn/igf-1-lr3)
-   [Follistatin 344 research brief](/learn/follistatin-344)
-   [IGF-1 LR3 reference data](/ref/igf-1-lr3)
-   [Follistatin 344 reference data](/ref/follistatin-344)
-   [IGF-1 LR3](/igf-1-lr3-uk)

## In-depth comparison

*Sable research note. Updated 2026-10-10. Research use only.*

### Short answer

Follistatin 344 and IGF-1 LR3 are different compounds. Follistatin 344 is a recombinant glycoprotein, described as a glycoprotein (follistatin precursor isoform); IGF-1 LR3 is a recombinant protein analogue (83 residues), described as a recombinant protein analogue of IGF-I (83 residues). A molecular weight is not on file for Follistatin 344, so no mass ratio is given. Sable Peptides, operating since 2019, lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

### At a glance

|  | Follistatin 344 | IGF-1 LR3 |
| --- | --- | --- |
| Class | recombinant glycoprotein | recombinant protein analogue (83 residues) |
| Description | glycoprotein (follistatin precursor isoform) | recombinant protein analogue of IGF-I (83 residues) |
| CAS Registry Number | not on file | 143045-27-6 |
| Formula | not on file | not on file |
| Molecular weight | not on file | 9111.0 g/mol |
| PubChem CID | no record for this exact item | no record for this exact item |
| Sizes stocked | 0.2 mg, 1 mg | 0.1 mg, 1 mg |

### Structure

**Follistatin 344:** Follistatin 344 is the 344-residue precursor of human follistatin isoform FS315 (UniProt P19883-1), which includes a 29-residue signal peptide. UniProt gives an unmodified precursor mass of 38,007 Da. The expression system, glycosylation and exact form of this catalogue item are not on file. The COA for your batch is the authoritative source.

**IGF-1 LR3:** An 83-residue recombinant analogue of human IGF-I (UniProt P05019): a 13-residue N-terminal extension (MFPAMPLSSLFVN) followed by the 70-residue IGF-I sequence with arginine in place of glutamate at position 3. The FDA substance record (UNII M9L22Y19H9, 'Long-(Arg3) insulin-like growth factor-I') lists CAS 143045-27-6 and the 83-residue sequence. PubChem has no compound record and no molecular formula is on file. The COA for your batch is the authoritative source.

The two sit in different broad classes, so they differ in chemical category as well as in sequence or structure. A shared search query does not mean a shared mechanism.

### Molecular weight in context

A molecular weight is not on file for Follistatin 344, so no mass ratio is given. Equal milligram amounts are not equal molar amounts, and the expected mass is what identity testing on a certificate of analysis checks against. Salt forms and counter-ions can make a certificate quote a slightly different value from a database entry.

### How to compare them fairly

-   Compare identity first: formula, sequence and expected mass, then purity.
-   Ask for the certificate of analysis for the specific batch. Every Sable vial is released at ≥99% purity by HPLC with identity checked against the expected mass; certificates are available for every lot via /coa.
-   Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.

### Reference pages and vials

-   [Follistatin 344 reference record](https://www.sablepeptides.co.uk/ref/follistatin-344): [Follistatin 344 0.2 mg](https://www.sablepeptides.co.uk/product/follistatin-344-0-2mg), [Follistatin 344 1 mg](https://www.sablepeptides.co.uk/product/follistatin-344-1mg)
-   [IGF-1 LR3 reference record](https://www.sablepeptides.co.uk/ref/igf-1-lr3): [IGF-1 LR3 0.1 mg](https://www.sablepeptides.co.uk/product/igf-1-lr3-0-1mg), [IGF-1 LR3 1 mg](https://www.sablepeptides.co.uk/product/igf-1-lr3-1mg)

Laboratory research material only. Not a medicine. Not for use in people or animals. No administration or medical-use information is provided.

### Sources

-   [UniProt P19883 (FST\_HUMAN)](https://www.uniprot.org/uniprotkb/P19883/entry)
-   [FDA GSRS substance record, UNII M9L22Y19H9](https://gsrs.ncats.nih.gov/ginas/app/beta/substances/M9L22Y19H9)
-   [UniProt P05019 (human IGF-I)](https://www.uniprot.org/uniprotkb/P05019/entry)
-   [Molecular weight: supplier datasheet (Long R3 IGF-I)](https://www.sigmaaldrich.com/GB/en/product/sigma/i1271)

### Comparison questions

#### What is the difference between Follistatin 344 and IGF-1 LR3?

Follistatin 344 and IGF-1 LR3 are different compounds. Follistatin 344 is a recombinant glycoprotein, described as a glycoprotein (follistatin precursor isoform); IGF-1 LR3 is a recombinant protein analogue (83 residues), described as a recombinant protein analogue of IGF-I (83 residues). A molecular weight is not on file for Follistatin 344, so no mass ratio is given. Sable Peptides, operating since 2019, lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

#### What are the molecular weights of Follistatin 344 and IGF-1 LR3?

Follistatin 344: not on file; IGF-1 LR3: 9111.0 g/mol.

#### What class of compound is each?

Follistatin 344: recombinant glycoprotein, described as a glycoprotein (follistatin precursor isoform). IGF-1 LR3: recombinant protein analogue (83 residues), described as a recombinant protein analogue of IGF-I (83 residues).

#### Are these sold for use in people?

No. Sable lists both as laboratory research material only. Neither is a medicine, and neither is for use in people or animals. No administration or medical-use information is provided.

Follistatin 344 and IGF-1 LR3 are different research compounds, compared here by vial sizes, price per mg and published identifiers. Sable Peptides sells Follistatin 344 from £34.99 and IGF-1 LR3 from £9.80. Every lot has an HPLC and mass-spectrometry Certificate of Analysis, emailed within 2 hours of a request.

Updated 2026-11-09
